Close

Spectrum Pharma (SPPI) Says Poziotinib Data in Lung Cancer to be Presented at IASLC

September 28, 2017 7:16 AM EDT Send to a Friend
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login